Edit |   |
---|---|
Antigenic Specificity | TNFA, Human (Placulumab biosimilar) |
Clone | Placulumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | [V kappa]2-Fc |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | WB, FCM, IP, ELISA, Neut, FuncS, IF |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human TNFA Recombinant Antibody (Placulumab). Placulumab is a human monoclonal antibody designed for the treatment of inflammatory diseases. This drug was developed by Teva Pharmaceutical Industries, Inc. As of 2012, development of placulumab has been discontinued. |
Immunogen | n/a |
Other Names | Anti-TNFA Recombinant Antibody, Research Grade Placulumab, Anti-Human TNFA Recombinant Antibody(Placulumab), ART621, CEP-37247, PN0621, Antibody Drug Analogues, Monoclonal Antibody, YR1289, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 945781-29-3 |
Catalog # | YR1289 |
Price | please inquire |
Order / More Info | TNFA, Human (Placulumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |